The methylation of CG sites in the DPP6 promoter was reported to be in greater numbers in tumor samples compared to normal samples from pancreatic ductal carcinoma; thus, the hypermethylation of DPP6 promoter is associated with poor overall survival [106]. Here, DPP6 is linked to pancreatic ductal adenocarcinoma.